✦ LIBER ✦

1057 The health economics of lung cancer and an estimate of the cost effectiveness of single agent gemcitabine in stage IV NSCLC

✍ Scribed by Evans, W.K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Economic evaluation of gemcitabine singl

✍ Gunnel Ragnarson Tennvall; Jan-Olof Fernberg 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 978 KB

A phase II study with vinorelbine, gemci

✍ Ginopoulos, P.; Mastronikolis, N.S.; Giannios, J.; Karana, A.; Siabi, V.; Karvel 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 77 KB

A multicenter phase II trial with gemcit

✍ E. Laack; T. Mende; J.G. Saal; A. Chemaissani; J. Scholtze; C. Lorenz; K. Dalhof 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 156 KB

The societal cost of alcohol consumption

✍ Johan Jarl; Pia Johansson; Antonina Eriksson; Mimmi Eriksson; Ulf-G. Gerdtham; Ö 📂 Article 📅 2007 🏛 Springer 🌐 French ⚖ 234 KB

The impact of new agents in the manageme

✍ Hansen, Heine H. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 90 KB

13 SYSTEMATIC REVIEW OF THE COST-EFFECTI

✍ Cao, J.; Rodrigues, G. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 39 KB